95 related articles for article (PubMed ID: 6106885)
21. Nadolol in thyrotoxicosis.
Peden NR; Isles TE; Stevenson IH; Crooks J
Br J Clin Pharmacol; 1982 Jun; 13(6):835-40. PubMed ID: 6124267
[TBL] [Abstract][Full Text] [Related]
22. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
[TBL] [Abstract][Full Text] [Related]
23. [Control of heart rate and atrial fibrillation].
Gardner MJ; Gilbert M
Can J Cardiol; 1996 Feb; 12 Suppl A():18A-21A. PubMed ID: 8673947
[No Abstract] [Full Text] [Related]
24. Nadolol, a once daily treatment for hypertension: multi-centre clinical evaluation.
Jackson DA
Br J Clin Pract; 1980 Jul; 34(7):211-21. PubMed ID: 6107120
[No Abstract] [Full Text] [Related]
25. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study.
Davy JM; Herold M; Hoglund C; Timmermans A; Alings A; Radzik D; Van Kempen L;
Am Heart J; 2008 Sep; 156(3):527.e1-9. PubMed ID: 18760136
[TBL] [Abstract][Full Text] [Related]
26. [Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina].
Romakov AIu; Sagirov AM; Desiatnichenko VM; Sobol' IuS; Sumarokov AB
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):57-63. PubMed ID: 6139118
[TBL] [Abstract][Full Text] [Related]
27. Comparative effects of nadolol-digoxin combination therapy and digoxin monotherapy for chronic atrial fibrillation.
Zoble RG; Brewington J; Olukotun AY; Gore R
Am J Cardiol; 1987 Aug; 60(6):39D-45D. PubMed ID: 3307366
[TBL] [Abstract][Full Text] [Related]
28. [Effectiveness of the prolonged-action beta-blockader nadolol in the treatment of ischemic heart disease].
Kirichenko AA; Aslibekian IS; Ivanova LN; Zurabian KM
Klin Med (Mosk); 1985 Oct; 63(10):88-92. PubMed ID: 2867247
[No Abstract] [Full Text] [Related]
29. Perceived exertion and gas exchange after calcium and beta-blockade in atrial fibrillation.
Myers J; Atwood JE; Sullivan M; Forbes S; Friis R; Pewen W; Froelicher V
J Appl Physiol (1985); 1987 Jul; 63(1):97-104. PubMed ID: 2887542
[TBL] [Abstract][Full Text] [Related]
30. [The treatment of atrial fibrillation with beta-adrenoblockers combined with fast sodium-channel blockers].
Denisiuk VI; Lepnitskiĭ TN; Kotsuta GI; Randin AG; Brovko EA
Ter Arkh; 1991; 63(11):119-22. PubMed ID: 1687340
[No Abstract] [Full Text] [Related]
31. [Action of betaxolol on ventricular arrhythmias. Control of efficacy and tolerance by repetitive Holter recordings].
Fillette F; Lebrun S; Malkawi K
Ann Cardiol Angeiol (Paris); 1985 Jun; 34(6):409-12. PubMed ID: 2862835
[TBL] [Abstract][Full Text] [Related]
32. [Decrease in ventricular frequency in auricular fibrillation using Visken].
Bender F; Dürholz HH; Gradaus D; Schmidt E
Med Welt; 1971 Feb; 9():340-1. PubMed ID: 4396541
[No Abstract] [Full Text] [Related]
33. Effects of metoprolol on heart rate in patients with digitalis treated chronic atrial fibrillation.
Khalsa A; Edvardsson N; Olsson SB
Clin Cardiol; 1978 Aug; 1(2):91-5. PubMed ID: 756821
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of cardioselective beta adrenergic blockade with intravenously administered tolamolol in the treatment of cardiac arrhythmias.
Amsterdam EA; Lee G; Morrison S; Tonkin MJ; DeMaria AN; Mason DT
Am J Cardiol; 1976 Aug; 38(2):195-9. PubMed ID: 7952
[TBL] [Abstract][Full Text] [Related]
35. Antifibrillatory actions of d,l-nadolol in a conscious canine model of sudden coronary death.
Patterson E; Lucchesi BR
J Cardiovasc Pharmacol; 1983; 5(5):737-44. PubMed ID: 6195459
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of hypotensive effect of nadolol].
Cybulska I; Brym E; Czerniewska E; Wołyńczyk-Niegowska J
Pol Arch Med Wewn; 1980 Dec; 64(6):475-80. PubMed ID: 6111065
[No Abstract] [Full Text] [Related]
37. Nadolol in hypertensive patients maintained on long-term hemodialysis.
Michaels RS; Duchin KL; Akbar S; Meister J; Levin NW
Am Heart J; 1984 Oct; 108(4 Pt 2):1091-4. PubMed ID: 6148869
[TBL] [Abstract][Full Text] [Related]
38. Prolonged effect of nadolol on heart rate in hyperthyroidism.
Adam RD; Parekh P; Harrower AD
Curr Med Res Opin; 1981; 7(4):212-4. PubMed ID: 6112117
[TBL] [Abstract][Full Text] [Related]
39. Nadolol and labetalol: comparative efficacy of two beta-blocking agents in glaucoma.
Krieglstein GK; Kontić D
Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 216(4):313-7. PubMed ID: 6114677
[TBL] [Abstract][Full Text] [Related]
40. [Clinical experience with a combination of a new beta-blocking agent, LB 46, and quinidine in the treatment of chronic atrial fibrillation].
Levi GF; Proto C
Minerva Cardioangiol; 1972 Feb; 20(2):92-5. PubMed ID: 4401589
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
